Pharmacological characterization of a series of aryl-sulfonamide derivatives that potently and selectively inhibit monoacylglycerol acyltransferase 2
详细信息 查看全文
- 作者：Ryutaro Adachi ; ryutaro.adachi@takeda.com" class="auth_mail" title="E-mail the corresponding author ; Tsuyoshi Ishii ; Kazumasa Ogawa ; Shinichi Matsumoto ; Takuya Satou ; Junichi Sakamoto ; Kenjiro Sato ; Tomohiro Kawamoto
- 关键词：Monoacylglycerol acyltransferase 2 ; Intestinal microsomes ; Affinity Selection Mass Spectrometry ; Cellular LC/MS assay ; Compound B
- 刊名：European Journal of Pharmacology
- 出版年：2016
- 出版时间：15 November 2016
- 年：2016
- 卷：791
- 期：Complete
- 页码：569-577
- 全文大小：679 K
文摘
Monoacylglycerol acyltransferase (MGAT) 2 is an endoplasmic reticulum membrane enzyme that catalyzes the synthesis of diacylglycerol (DAG) from fatty acyl-CoA and monoacylglycerol as substrates. It is important for the resynthesis of triacylglycerol in the intestine. We have identified a series of aryl-sulfonamide MGAT2 inhibitors and demonstrated pharmacological inhibition of MGAT2 improved hyperlipidemia, obesity, and diabetes in animal models. However, its mechanism of action has not been elucidated in molecular and cellular levels. In the present study, we have characterized a series of aryl-sulfonamide derivatives that potently and selectively inhibit human MGAT2 and determined their pharmacological profiles. Analyses on the molecular mechanism of a representative aryl-sulfonamide MGAT2 inhibitor revealed a reversible inhibitory activity and a binding activity to MGAT2. The aryl-sulfonamide derivatives exhibited potent inhibitory activities against both human and mouse intestinal MGAT activities, which were correlated to those determined using recombinant human and mouse MGAT enzymes. We have developed a cellular assay using Liquid Chromatography-Mass Spectrometry and confirmed that the aryl-sulfonamide derivatives suppressed DAG synthesis in the cellular context. We have thus elucidated their pharmacological profiles and provided the fundamental clues for understanding the molecular and cellular actions of the aryl-sulfonamide MGAT2 inhibitors.